AVEO PHARMACEUTICALS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - February 8, 2010

Attached files

file filename
EX-10.7 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT - AVEO PHARMACEUTICALS, INC.dex107.htm
EX-3.5 - SECOND AMENDED AND RESTATED BYLAWS - AVEO PHARMACEUTICALS, INC.dex35.htm
EX-10.5 - 2010 STOCK INCENTIVE PLAN - AVEO PHARMACEUTICALS, INC.dex105.htm
EX-10.6 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - AVEO PHARMACEUTICALS, INC.dex106.htm
EX-10.1 - 2002 STOCK INCENTIVE PLAN, AS AMENDED - AVEO PHARMACEUTICALS, INC.dex101.htm
EX-10.17 - 2010 EMPLOYEE STOCK PURCHASE PLAN - AVEO PHARMACEUTICALS, INC.dex1017.htm
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - AVEO PHARMACEUTICALS, INC.ds1a.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 8, 2010, in amendment No. 2 to the Registration Statement (Form S-1 No. 333-163778) and related Prospectus of AVEO Pharmaceuticals, Inc., dated February 8, 2010.

/s/    Ernst & Young LLP

Boston, Massachusetts

February 8, 2010

AVEO PHARMACEUTICALS, INC. Reports